Browse > Article

Definitive Nomenclature of GES/IBC-Type Extended-Spectrum ${\beta}-Lactamases$  

Weldhagen Gerhard F. (Molecular Biology Laboratory, AMPATH National Laboratory Services and Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria)
Kim, Bok-Hee (Bio Technology Innovation Center, Youngdong University)
Cho, Chan-Hwi (Bio Technology Innovation Center, Youngdong University)
Lee, Sang-Hee (Bio Technology Innovation Center, Youngdong University)
Publication Information
Journal of Microbiology and Biotechnology / v.16, no.11, 2006 , pp. 1837-1840 More about this Journal
Abstract
Because there are no unified nomenclature systems for either GES-type or IBC-type extended-spectrum ${\beta}-lactamases$ (ESBLs), we propose a unified and definitive nomenclature system for GES/IBC-type ESBLs. This proposed nomenclature update is greatly helpful in two points: (i) it would not confuse microbiologists studying GES-type ESBLs, fundamentally preventing misleading nomenclature of these antibiotic resistance genes, and (ii) the definitive renaming of GES/IBC-type ESBLs can help some researchers to correctly designate new GES-type ESBLs such as novel enzymes identified trom some nationwide surveys.
Keywords
Nomenclature; extended-spectrum ${\beta}-lactamase$; GES-type; IBC-type;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
Times Cited By Web Of Science : 4  (Related Records In Web of Science)
연도 인용수 순위
1 Duarte, A., F. Boavida, F. Grosso, M. Correia, L. M. Lito, J. Melo Cristino, and M. J. Salgado. 2003. Outbreak of GES-1 ${\beta}$-lactamase-producing multidrug-resistant Klebsiella pneumoniae in a university hospital in Lisbon, Portugal. Antimicrob. Agents Chemother. 47: 1481-1482   DOI
2 Giakkoupi, P., L. S. Tzouvelekis, A. Tsakris, V. Loukova, D. Sofianou, and E. Tzelepi. 2000. IBC-1, a novel integron-associated class A ${\beta}$-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain. Antimicrob. Agents Chemother. 44: 2247-2253   DOI
3 Jeong, S. H., I. K. Bae, D. Kim, S. G. Hong, J. S. Song, J. H. Lee, and S. H. Lee. 2005. First outbreak of Klebsiella pneumoniae clinical isolates producing GES-5 and SHV-12 extended-spectrum ${\beta}$-lactamases in Korea. Antimicrob. Agents Chemother. 49: 4809-4810   DOI   ScienceOn
4 Paterson, D. L., W.-C. Ko, A. Von Gottberg, J. M. Casellas, L. Mulazimoglu, K. P. Klugman, R. A. Bonomo, L. B. Rice, J. G. McCormack, and V. L. Yu. 2001. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum ${\beta}$-lactamases: Implications for the clinical microbiology laboratory. J. Clin. Microbiol. 39: 2206-2212   DOI   ScienceOn
5 Poirel, L., I. Le Thomas, T. Naas, A. Karim, and P. Nordmann. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum ${\beta}$-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44: 622-632   DOI
6 Vourli, S., P. Giakkoupi, V. Miriagou, E. Tzelepi, A. C. Vatopoulos, and L. S. Tzouvelekis. 2004. Novel GES/IBC extended-spectrum ${\beta}$-lactamase variants with carbapenemase activity in clinical enterobacteria. FEMS Microbiol. Lett. 234: 209-213
7 Wachino, J.-I., Y. Doi, K. Yamane, N. Shibata, T. Yagi, T. Kubota, and Y. Arakawa. 2004. Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A ${\beta}$-lactamase, GES-4, possessing a single G170S substitution in the ${\Omega}$-loop. Antimicrob. Agents Chemother. 48: 2905-2910   DOI   ScienceOn
8 Wachino, J.-I., Y. Doi, K. Yamane, N. Shibata, T. Yagi, T. Kubota, H. Ito, and Y. Arakawa. 2004. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class A ${\beta}$-lactamase, GES-3, in a neonatal intensive care unit in Japan. Antimicrob. Agents Chemother. 48: 1960-1967   DOI   ScienceOn
9 Bradford, P. A. 2001. Extended-spectrum ${\beta}$-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14: 933-951   DOI   ScienceOn
10 Lee, S. H., S. H. Jeong, J.-I. Wachino, T. Arakawa, L. Poirel, and P. Nordmann. 2005. Nomenclature of GES-type extended-spectrum ${\beta}$-lactamases. Antimicrob. Agents Chemother. 49: 2148-2150   DOI   ScienceOn
11 Sanders, C. C. and W. E. Jr. Sanders. 1992. ${\beta}$-Lactamase in Gram-negative bacteria: Global trends and clinical impact. Clin. Infect. Dis. 15: 824-839   DOI   ScienceOn
12 Lee, S. H., S. H. Jeong, and S.-S. Cha. 2005. Minimising antibiotic resistance. Lancet Infect. Dis. 5: 668-670   DOI   ScienceOn
13 Pasteran, F., D. Faccone, A. Petroni, M. Rapoport, M. Galas, M. Vazquez, and A. Procopio. 2005. Novel variant $(bla_{VIM-11})$ of the metallo-${\beta}$-lactamase $bla_{VIM}$ family in a GES-1 extended-spectrum-${\beta}$-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina. Antimicrob. Agents Chemother. 49: 474-475   DOI   ScienceOn
14 Poirel, L., L. Brinas, N. Fortineau, and P. Nordmann. 2005. Integron-encoded GES-type extended-spectrum ${\beta}$-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49: 3593-3597   DOI   ScienceOn
15 Lee, J. H. and S. H. Lee. 2006. Carbapenem resistance in Gram-negative pathogens: Emerging non-metallo-carbapenemases. Res. J. Microbiol. 1: 1-22   DOI
16 Jung, H. J., K. S. Choi, and D. G. Lee. 2005. Synergistic killing effect of synthetic peptide P20 and cefotaxime on methicillin-resistant nosocomial isolates of Staphylococcus aureus. J. Microbiol. Biotechnol. 15: 1039-1046   과학기술학회마을
17 Rhie, H. G., S. J. Lee, and H. S. Lee. 2004. Characterization of the plasmid-encoded arsenic salts resistance determinant from Klebsiella oxytoca D12. J. Microbiol. Biotechnol. 14: 593-598
18 Correia, M., F. Boavida, F. Grosso, M. J. Salgado, L. M. Lito, J. Melo Cristino, S. Mendo, and A. Duarte. 2003. Molecular characterization of a new class 3 integron in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 47: 2838-2843   DOI
19 Kim, J. N., S. J. Lee, H. S. Lee, and H. G. Rhie. 2005. Inactivation of mutS leads to a multiple-drug resistance in Pseudomonas putida ATCC12633. J. Microbiol. Biotechnol. 15: 1214-1220   과학기술학회마을
20 Ryoo, N. H., E.-C. Kim, S. G. Hong, Y. J. Park, K. Lee, I. Kwon Bae, E. H. Song, and S. H. Jeong. 2005. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J. Antimicrob. Chemother. 56: 698-702   DOI   ScienceOn
21 Mavroidi, A., E. Tzelepi, A. Tsakris, V. Miriagou, D. Sofianou, and L. S. Tzouvelekis. 2001. An integron-associated ${\beta}$-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum ${\beta}$-lactamase IBC-1. J. Antimicrob. Chemother. 48: 627-630   DOI   ScienceOn
22 Pasteran, F., D. Faccone, K. Campos, M. Vasquez, M. Rapoport, A. Littvik, M. Tokumoto, and M. Galas. 2004. Dissemination of GES extended-spectrum ${\beta}$-lactamase-producing Pseudomonas aeruginosa (PA) in Argentina. Abstr. 44th Intersci. Conf. Antimicrob. Agents Chemother., abstr. 105. American Society for Microbiology, Washington, D.C
23 Hall, R., S. Partridge, P. A. Bradford, K. Bush, G. A. Jacoby, L. B. Rice, and L. S. Young. 2003. Unambiguous numbering of antibiotic resistance genes. Antimicrob. Agents Chemother. 47: 3998-3999   DOI
24 George, H. T., J. Bradley, J. E. Edwards Jr., D. Gilbert, M. Scheld, and J. G. Bartlett. 2006. Bad bugs need drugs; an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis. 42: 657-668   DOI   ScienceOn
25 Poirel, L., G. F. Weldhagen, T. Naas, C. De Champs, M. G. Dove, and P. Nordmann. 2001. GES-2, a class A ${\beta}$-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob. Agents Chemother. 45: 2598-2603   DOI
26 Castanheira, M., R. E. Mendes, T. R. Walsh, A. C. Gales, and R. N. Jones. 2004. Emergence of the extended-spectrum ${\beta}$-lactamase GES-1 in a Pseudomonas aeruginosa strain from Brazil: Report from the SENTRY antimicrobial surveillance program. Antimicrob. Agents Chemother. 48: 2344-2345   DOI   ScienceOn
27 Weldhagen, G. F. 2004. Rapid detection and sequence-specific differentiation of extended-spectrum ${\beta}$-lactamase GES-2 from Pseudomonas aeruginosa by use of a real-time PCR assay. Antimicrob. Agents Chemother. 48: 4059-4062   DOI   ScienceOn
28 Cho, B. G., C. H. Kim, B. K. Lee, and S. H. Cho. 2005. Comparison of antibiotic resistance of blood culture strains and saprophytic isolates in the presence of biofilms, formed by the intercellular adhesion (ica) gene cluster in Staphylococcus epidermidis. J. Microbiol. Biotechnol. 15: 728-733   과학기술학회마을
29 Livermore, D. M. 1995. ${\beta}$-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8: 557-584